Mizuho Securities Remains Sidelined on Yahoo! (YHOO) Following 3Q Report and Guidance
- Wall Street rally continues as laggards advance
- Trump's Cohn Pick Most Bullish Sign Yet for Banks - Cowen
- Unusual 11 Mid-Day Movers: (IDXG) (INVN) (EBS) Higher; (SCON) (DTEA) (DLTH) Lower (more...)
- 21st Century Fox (FOXA) offers to acquire Sky for GBP10.75/share
- Coca Cola (KO) Announces James Quincey to Succeed Muhtar Kent as CEO; Kent to Continue as Chairman
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Mizuho Securities reiterated a Neutral rating on Yahoo! (NASDAQ: YHOO), and raised the price target to $42.00 (from $38.00), following the company's 3Q earnings report. 3Q revenues of $858m was slightly behind the Street's expectations of $861m. Non-GAAP EPS of $0.20 was ahead of expectations of $0.14. For 4Q16, the company's midpoint revenue guidance of $900m was below the Street's $937m estimate, but its EBITDA guide of $280m was better than the Street's $245m.
Analyst Neil A. Doshi commented, "Yahoo posted mixed 3Q results. Its primary growth engine, Mavens, declined 6% YoY with weakness in network video and Search continued to decline. Yahoo did show higher traffic and engagement in September on Yahoo Mail post the data breach, which gives us increasing confidence that the VZ-YHOO deal should remain on track. And YHOO posted a nice EBITDA beat and raise on continued op leverage. We maintain our Neutral rating, but we are raising our PT from $38 to $42 to account for updated pricing on shares of BABA."
Shares of Yahoo! closed at $41.68 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MKM Partners Raises Price Target on Broadcom Ltd. (AVGO) to $207 Following 4Q Beat
- UBS Raises Price Target on Selecta Biosciences (SELB) to $29
- KLR Group Cuts Price Target on Bill Barrett (BBG) to $9; Reiterates Buy
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!